The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
So clearly AC has known for a while we’ve a problem in Tunisia as he’s had time to line the lawyers up.
Clearly us PIs didn’t get told at the earliest opportunity there is a problem via RNS…
Sadly all the rampers now have left on their repertoire is to revert to personal attacks to defend Zen.
At the end of the day (fact) is she share price went 10p > 14p > 0.425p today over the time they’ve been trading.
Is that good performance for shareholders? Is that justifying all the equity raises and dilution over the years? Oh and does that justify AC’s $2m CAD remuneration package while all PIs are sat on big losses?
Looking forward to release of the next annual report!!
Funny how
FTSE is 1.4% up
Zen is main market (not aim so AC repeatedly reminds us) and yet on this apparent “good” news day we’ll likely finish flat with just 5/6 trades!!!
Suggests to me a lack of trust / scepticism.
News on the Tunisian lifts and the other outstanding items would add some trust. Over to you Zen / AC….
Zen did similar prior to the announcement Azerbaijan was kaput. Diverted attention elsewhere to a potential new acquisition before then announcing Az had failed.
Feels like with all the silence we've been seeing of late perhaps they've been busy behind the scenes to find something else to excite us with before bad news to come.
Maybe. But all this is just my hunch based on Zen's prior lack of successes / track record over last 5y...